|
|
Suppliers for
Trilostane
|
Properties | CAS |
13647-35-3 | Formula |
C20H27NO3 | EINECS |
237-133-0 |
|
|
24 Registered suppliers
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Description | White to off-white power
| Purity | 98.5%min
| Water(K.F) | ≤ 0.5%
| Loss on drying | ≤ 0.5%
| Residue on ignition | ≤ 0.1%
| Heavy metals | ≤ 20ppm
| Specific optional rotation | +137°~ +139° |
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
Molecular Formula: C20H27NO3 Molecular Weight: 329.43 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29372900
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Description : Trilostane is an inhibitor of 3β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It is used for the treatment of pituitary-dependent adrenocortical hormone hyperplasia in dogs and the treatment of adrenocortical hormone hyperplasia caused by adrenal cortex tumors in dogs. - Molecular Weight :329.43
- Boiling Point :516.5°C at 760 mmHg
- Melting Point :264°C
- Purity :> 98%
Molecular Formula : C20H27NO3 Canonical SMILES : CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C InChI : InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 InChIKey : KVJXBPDAXMEYOA-CXANFOAXSA-N Solubility : Soluble in DMSO (17 mg/mL) Appearance : Yellow-brown Crystalline Solid Storage : Store at -20°C Synonyms : WIN24540; WIN-24540; WIN 24540; Trilostane; DB01108; D-01180; D 01180; Modrastane. Desopan; Modrenal.
More details are to be found here
Detailed information on the suppliers of
Trilostane
|
Properties:
... more properties and specification on Trilostane
|
|
Privileged suppliers
Last update 2024-04-24
|